Examining Rural-Urban Differences in Fatalism and Information Overload: Data from 12 NCI-Designated Cancer Centers.


Journal

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
ISSN: 1538-7755
Titre abrégé: Cancer Epidemiol Biomarkers Prev
Pays: United States
ID NLM: 9200608

Informations de publication

Date de publication:
02 2022
Historique:
received: 20 03 2021
revised: 01 07 2021
accepted: 02 12 2021
pubmed: 30 1 2022
medline: 9 3 2022
entrez: 29 1 2022
Statut: ppublish

Résumé

Rural populations experience a disproportionate cancer burden relative to urban populations. One possibility is that rural populations are more likely to hold counterproductive cancer beliefs such as fatalism and information overload that undermine prevention and screening behaviors. Between 2016 and 2020, 12 U.S. cancer centers surveyed adults in their service areas using online and in-person survey instruments. Participants ( Compared with urban residents, rural residents were more likely to believe that (i) everything causes cancer (OR = 1.29; 95% CI, 1.17-1.43); (ii) prevention is not possible (OR = 1.34; 95% CI, 1.19-1.51); and (iii) there are too many different recommendations about cancer prevention (OR = 1.26; 95% CI, 1.13-1.41), and cancer is always fatal (OR = 1.21; 95% CI, 1.11-1.33). Compared with their urban counterparts, rural populations exhibited higher levels of cancer fatalism and cancer information overload. Future interventions targeting rural populations should account for higher levels of fatalism and information overload.

Sections du résumé

BACKGROUND
Rural populations experience a disproportionate cancer burden relative to urban populations. One possibility is that rural populations are more likely to hold counterproductive cancer beliefs such as fatalism and information overload that undermine prevention and screening behaviors.
METHODS
Between 2016 and 2020, 12 U.S. cancer centers surveyed adults in their service areas using online and in-person survey instruments. Participants (
RESULTS
Compared with urban residents, rural residents were more likely to believe that (i) everything causes cancer (OR = 1.29; 95% CI, 1.17-1.43); (ii) prevention is not possible (OR = 1.34; 95% CI, 1.19-1.51); and (iii) there are too many different recommendations about cancer prevention (OR = 1.26; 95% CI, 1.13-1.41), and cancer is always fatal (OR = 1.21; 95% CI, 1.11-1.33).
CONCLUSIONS
Compared with their urban counterparts, rural populations exhibited higher levels of cancer fatalism and cancer information overload.
IMPACT
Future interventions targeting rural populations should account for higher levels of fatalism and information overload.

Identifiants

pubmed: 35091459
pii: 1055-9965.EPI-21-0355
doi: 10.1158/1055-9965.EPI-21-0355
pmc: PMC9035270
mid: NIHMS1763749
doi:

Types de publication

Comparative Study Journal Article Multicenter Study Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

393-403

Subventions

Organisme : NCI NIH HHS
ID : P30 CA077598
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA015704
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA168524
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA047904
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA082709
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA177558
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016058
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016059
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002366
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA042014
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA069533
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA044579
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA013148
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

©2022 American Association for Cancer Research.

Références

Med Anthropol Q. 2011 Jun;25(2):164-82
pubmed: 21834356
J Epidemiol Community Health. 2019 Dec;73(12):1128-1135
pubmed: 31615890
Rural Remote Health. 2019 Aug;19(3):5181
pubmed: 31394041
J Rural Health. 2019 Mar;35(2):141-143
pubmed: 30830981
Health Place. 2009 Sep;15(3):731-40
pubmed: 19211295
Cancer Epidemiol Biomarkers Prev. 2018 Nov;27(11):1265-1274
pubmed: 28751476
J Rural Health. 2019 Mar;35(2):176-188
pubmed: 30830984
Int J Epidemiol. 2020 Feb 1;49(1):17-17j
pubmed: 31038687
Patient Educ Couns. 2020 Jan;103(1):15-32
pubmed: 31451363
Patient Educ Couns. 2020 Feb;103(2):309-314
pubmed: 31522897
J Health Commun. 2004 Sep-Oct;9(5):443-60; discussion 81-4
pubmed: 15513791
Public Health. 2015 Jun;129(6):611-20
pubmed: 26025176
J Rural Health. 2015 Spring;31(2):199-205
pubmed: 25640763
Int J Behav Med. 2011 Dec;18(4):310-8
pubmed: 20953916
Patient Educ Couns. 2014 Jan;94(1):90-6
pubmed: 24268921
Public Underst Sci. 2016 Jul;25(5):627-36
pubmed: 25550403
Risk Anal. 2017 Jan;37(1):40-51
pubmed: 26973157
Health Mark Q. 2016 Jul-Sep;33(3):206-20
pubmed: 27484742
J Commun. 2012 Dec;62(6):972-990
pubmed: 25530627
Fam Community Health. 2011 Apr-Jun;34(2):126-33
pubmed: 21378509
MMWR Surveill Summ. 2017 Jul 07;66(14):1-13
pubmed: 28683054
Soc Sci Med. 2014 Mar;104:31-40
pubmed: 24581059
Soc Sci Med. 2018 Dec;219:11-18
pubmed: 30342382
J Cancer Educ. 2013 Sep;28(3):521-6
pubmed: 23813489
Health Commun. 2020 Mar;35(3):322-330
pubmed: 30606065
Cancer Nurs. 2003 Dec;26(6):454-65; quiz 466-7
pubmed: 15022977
Sociol Health Illn. 2009 Jul;31(5):734-47
pubmed: 19392939
J Cancer Educ. 2019 Oct;34(5):958-965
pubmed: 30022378
Cancer Epidemiol Biomarkers Prev. 2017 Aug;26(8):1192-1208
pubmed: 28515109
Ann Int Commun Assoc. 2017;41(3-4):298-320
pubmed: 34307882
Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):998-1003
pubmed: 17507628
MMWR Surveill Summ. 2017 Feb 03;66(5):1-8
pubmed: 28151923
Health Educ Res. 2002 Oct;17(5):670-9
pubmed: 12408211
J Commun. 2010 Jun 1;60(2):230-253
pubmed: 20563221
Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):486-494
pubmed: 30700446
Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1701-8
pubmed: 23045545
J Rural Health. 2017 Sep;33(4):402-405
pubmed: 28685889
J Cancer Educ. 2021 Feb;36(1):3-9
pubmed: 32648238
CA Cancer J Clin. 2012 Jan-Feb;62(1):30-67
pubmed: 22237782
Pers Soc Psychol Rev. 1999;3(4):303-25
pubmed: 15661679
J Health Commun. 2010;15 Suppl 3:78-91
pubmed: 21154085
Psychol Health. 2009 Jun;24(5):597-613
pubmed: 20205014
J Rural Health. 2016 Winter;32(1):35-43
pubmed: 26171848
Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):992-997
pubmed: 28600296
Cancer. 2013 Mar 1;119(5):1050-7
pubmed: 23096263

Auteurs

Jakob D Jensen (JD)

Department of Communication, University of Utah, Salt Lake City, Utah. jakob.jensen@utah.edu.
Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.

Jackilen Shannon (J)

Oregon Health and Science University - Portland State University, School of Public Health, Oregon Health and Science University, Portland, Oregon.

Ronaldo Iachan (R)

ICF, Rockville, Maryland.

Yangyang Deng (Y)

ICF, Rockville, Maryland.

Sunny Jung Kim (SJ)

Department of Health Behavior and Policy, Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia.

Wendy Demark-Wahnefried (W)

Department of Nutrition Sciences and O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama.

Babalola Faseru (B)

Department of Population Health, University of Kansas Medical Center, Kansas City, Kansas.
University of Kansas Cancer Center, Kansas City, Kansas.

Electra D Paskett (ED)

Department of Internal Medicine, College of Medicine, and OSU Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.

Jinxiang Hu (J)

University of Kansas Cancer Center, Kansas City, Kansas.
Department of Biostatistics and Data Science, University of Kansas Medical Center, Kansas City, Kansas.

Robin C Vanderpool (RC)

Department of Health, Behavior and Society and Markey Cancer Center, University of Kentucky, Lexington, Kentucky.

DeAnn Lazovich (D)

Division of Epidemiology and Community Health and Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.

Jason A Mendoza (JA)

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center and Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington.

Sanjay Shete (S)

Department of Biostatistics and Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Linda B Robertson (LB)

School of Medicine and UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania.

Rajesh Balkrishnan (R)

Department of Public Health Sciences and UVA Cancer Center, University of Virginia, Charlottesville, Virginia.

Katherine J Briant (KJ)

Office of Community Outreach and Engagement, Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington.

Benjamin Haaland (B)

Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
Department of Population Sciences, University of Utah, Salt Lake City, Utah.

David A Haggstrom (DA)

School of Medicine, Indiana University, Indianapolis, Indiana.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH